Resistance of a variant ras-transformed cell line to phenotypic reversion by farnesyl transferase inhibitors

Cancer Research

Volumn 56, Issue 11, 1996, Pages 2626-2632

  Prendergast, George C ^a,b   Davide, Joseph P ^b   Lebowitz, Peter F ^a   Wechsler Reya, Robert ^a   Kohl, Nancy E ^b  

^a WISTAR INSTITUTE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; LAMIN B; N [2 [2 (2 AMINO 3 MERCAPTOPROPYLAMINO) 3 METHYLPENTYLOXY] 3 PHENYLPROPIONYL]METHIONINE SULFONE METHYL ESTER; PROTEIN FARNESYLTRANSFERASE; RAS PROTEIN;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG RESISTANCE; GROWTH INHIBITION; NONHUMAN; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL; RAT; REVERTANT;

ACTINS; ALKYL AND ARYL TRANSFERASES; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETON; DRUG RESISTANCE; ENZYME INHIBITORS; FARNESYLTRANSTRANSFERASE; GENES, RAS; GTP-BINDING PROTEINS; MEMBRANE PROTEINS; MYRISTATES; OLIGOPEPTIDES; PHENOTYPE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RHOB GTP-BINDING PROTEIN; TRANSFERASES; TUMOR CELLS, CULTURED;

EID: 0029952467     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bos, J. L. ras gene mutations and human cancer. In: J. Cossman (ed.). Molecular Genetics in Cancer Diagnosis, pp. 273-287. Amsterdam: Elsevier Science Publishers, B.V. 1990.
2. Lowy, D., and Willumsen, B. Regulators and effectors of Ras. Annu. Rev Biochem , 62: 851-891, 1993.
3. Prendergast, G. C., and Gibbs, J. B. Pathways of Ras function: connections to the actin cytoskeleton. Adv Cancer Res , 62: 19-63, 1993
4. Georges, R N , Mukhopadhyay, T., Zhang, Y., Yen, N., and Roth, J. A. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct. Cancer Res. 53 1743-6, 1993.
5. Shirasawa, S , Furuse, M., Yokoyama, N., and Sasazuki, T. Altered growth of human colon cancer cell lines disrupted at activated Ki-Ras. Science (Washington DC), 260: 85-88, 1993.
6. Gibbs, J. B. Lipid modifications of proteins in the Ras superfamily. In: L Birnbaumer and B. Dickey (eds.). GTPases in Biology, pp. 335-344. New York: Springer-Verlag, 1993
7. Khosravi-Far, R , Cox, A D., Kato, K , and Der, C. Protein prenylation: key to Ras function and cancer intervention? Cell Growth & Differ., 3: 461-469, 1992.
8. Kato, K., Cox, A D., Hisaka, M. M., Graham, S. M., Buss, J. E , and Der, C J. Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity Proc Natl. Acad. Sci. USA. 89: 6403-6407, 1992.
9. Garcia, A. M , Rowell, C., Ackermann, K., Kowalczyk, J. J , and Lewis, M. D. Peptidomimetic inhibitors of Ras farnesylation and function in whole cells. J Biol. Chem., 268: 18415-18418, 1993.
10. James, G L., Goldstein, J L., Brown, M. S , Rawson, T. E., Somers, T C , McDowell, R. S , Crowley, C W , Lucas, B. K , Levinson, A. D., and Marsters, J. C. Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells Science (Washington DC), 260: 1937-1942, 1993
11. Kohl, N E., Mosser, S D , deSolms, S. J., Giuliani, E. A., Pompliano, D L , Graham, S L , Smith, R. L., Scolnick, E. M., Oliff, A , and Gibbs, J. B. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science (Washington DC), 260: 1934-1937, 1993.
12. Manne, V , Yan, N , Carboni, J. M , Tuomari, A V , Ricca, C. S , Brown, J. G., Andahazy, M. L., Schmidt, R. J., Patel, D., Zahler, R., Weinmann, R , Der, C J , Cox, A. D , Hunt, J. T., Gordon, E. M., Barbacid, M., and Seizinger, B. R Bisubstrate inhibitors of farnesyltransferase a novel class of specific inhibitors of ras transformed cells. Oncogene, 10: 1763-1779, 1995
13. Kohl, N E., Omer, C A., Conne,. M. W , Anthony, N. J., Davide, J P , deSolms, S J, Giuliani, E A, Gomez, R P., Graham, S. L., Hamilton, K., Handt, L K , Hartman, G D , Koblan, K S., Kral, A. M., Miller, P. J., Mosser, S. D., O'Neill, T J , Rands, E., Schaber, M. D., Gibbs, J B., and Oliff, A. Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nat. Med., 1. 792-797, 1995.
14. Kohl, N E , Redner, F , Mosser, S., Giuliani, E. A., deSolms, S. J., Conner, M. W., Anthony, N. J., Holtz, W. J., Gomez, R. P., Lee, T-J., Smith, R. L., Graham, S. L., Hartman, G D., Gibbs, J , and Oliff, A Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice. Proc Natl Acad. Sci USA, 91: 9141-9145, 1994.
15. Lebowitz, P. F., Davide, J. P., and Prendergast, G. C Evidence that farnesyl transferase inhibitors suppress Ras transformation by interfering with Rho activity Mol. Cell. Biol., 15, 6613-6622, 1995.
16. Prendergast, G. C., Davide, J. P., deSolms, S. J., Giuliani, E., Graham, S , Gibbs, J. B., Oliff, A., and Kohl, N. E. Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton. Mol. Cell. Biol., 14: 4193-4202, 1994.
17. Pompliano, D. L , Rands, E., Schaber, M. D., Messer, S. D., Anthony, N. J., and Gibbs, J. B Steady-state kinetic mechanism of Ras farnesyl:protein transferase. Biochemistry. 31: 3800-3807, 1992.
18. Sepp-Lorenzino, L., Ma, Z., Rands, E., Kohl, N. E., Gibbs, J. B., Oliff, A., and Rosen, N A peptidomimetic inhibitor of farnesyl.protein transferase blocks the anchorage- dependent and -independent growth of human lumor cell lines Cancer Res., 55: 5302-5309, 1995.
19. Farnsworth, C. C , Wolda, S. L., Gelb, M. H., and Glomset, J. A. Human lamin B contains a farnesylated cysteine residue J. Biol. Chem., 264, 20422-20429, 1989.
20. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug-resistance mediated by the multidrug transporter Annu. Rev. Biochem , 62: 385-427, 1993.
21. Cox, A. D.. Hisaka, M. M., Buss, J E., and Der, C. J Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras function. Mol. Cell Biol., 12: 2606-2615, 1992
22. Kohl, N E., Diehl, R. E , Schaber, M. D., Rands, E , Soderman, D. D., He, B., Moores, S. L , Pompliano, D. L , Ferro-Novick, S., Powers, S., Thomas, K A., and Gibbs, J. B. Structural homology among mammalian and Saccharomyces cerevisiae isoprenyl-protein transferases. J. Biol. Chem , 266: 18884-18888, 1991.
23. Smith, M. R., DeGudicibus, S. J., and Stacey, D. W. Requirement for c-ras proteins during viral oncogene transformation. Nature (Lond.), 320: 540-543, 1986.
24. Shih, T. Y., Stokes, P. E., Smythers, G. W., Dhar, R., and Oroszlan, S. Characterization of the phosphorylation sites and the surrounding amino acid sequences of the p21 transforming proteins coded for by the Harvey and Kirsten strains of murine sarcoma viruses. J. Biol. Chem., 257 11767-11773, 1982.